Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Nanobiotix S.A. - Sponsored ADR (NBTX) had Stock-Based Compensation of $2.45M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$45.28M |
|
$5.52M |
|
$6.00M |
|
$51.28M |
|
$71.56M |
|
-- |
|
$58.00M |
|
$129.56M |
|
$-78.27M |
|
$-78.29M |
|
$-78.27M |
|
48.24M |
|
| Cash Flow Statement Financials | |
$-19.77M |
|
$-0.18M |
|
$-3.21M |
|
$56.46M |
|
$32.71M |
|
$-23.75M |
|
|
Stock-Based Compensation |
$2.45M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|